Skip to main content

... And Shares Climb 5 Percent After Firm Announces MassArray Add-On Launch

NEW YORK, March 16 (GenomeWeb News) - Shares of Sequenom were up 5 percent, or $.04, at $.76 in afternoon trading after the company launched two new products for the MassARRAY system.


The EpiTYPER assay for DNA methylation marker research and the QGE iPLEX multiplex assay for gene expression are commercially available and will be presented at the American Association of Cancer Research annual conference in April, said the company in a statement.


Price information was not released.


"With the launch of these new products, we are delivering on our product goals for the first quarter of 2006," said Harry Stylli, president and CEO of Sequenom.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.